Interferon subverts an AHR–JUN axis to promote CXCL13+ T cells in lupus - Nature
Insufficient AHR activation has been suggested in SLE, and augmenting AHR activation therapeutically may prevent CXCL13+ TPH/TFH differentiation and the subsequent recruitment of B cells and formation of lymphoid aggregates in inflamed tissues.